- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| 市场准入经理 | Fuzhou (Fujian Province) | China | International | Innovative Medicines | Market Access | Jan 07, 2025 |
| V&A Specialist | Taipei | Taiwan | International | Innovative Medicines | Market Access | Jan 06, 2025 |
| 市场准入大区经理 | Wuhan (Hubei Province) | China | International | Innovative Medicines | Market Access | Jan 06, 2025 |
| Sr. HEOR & Access Strategy Manager | Shanghai (Shanghai) | China | International | Innovative Medicines | Market Access | Dec 19, 2024 |
| Associate Director, Market Access Early Pipeline & BD&L - Remote | Remote Position (USA) | USA | US | Innovative Medicines | Market Access | Dec 16, 2024 |
| Head of Strategic Access and Partnerships | Mumbai (Head Office) | India | International | Innovative Medicines | Market Access | Dec 16, 2024 |
| Head Market Access | Mumbai (Head Office) | India | International | Innovative Medicines | Market Access | Dec 16, 2024 |
| Key Account Manager | Guatemala | Guatemala | International | Innovative Medicines | Market Access | Dec 16, 2024 |
| Market Access Lead/Senior Lead | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Market Access | Dec 15, 2024 |
| Pricing, Value & Access Lead | Kazakhstan | Kazakhstan | International | Innovative Medicines | Market Access | Dec 11, 2024 |
| AD, Access & Reimbursement RLT - Remote - Manhattan/Long Island | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Dec 11, 2024 |
| HEOR Manager | London (The Westworks) | United Kingdom | International | Innovative Medicines | Market Access | Dec 05, 2024 |
| Director, US HEOR Product Lead - RLT | Remote Position (USA) | USA | US | Innovative Medicines | Market Access | Dec 04, 2024 |
| Associate Director RWE Manager | Dublin (NOCC) | Ireland | Operations | CTS | Market Access | Dec 03, 2024 |
| AD, Access & Reimbursement RLT San Francisco, CA - Remote | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Dec 03, 2024 |
| AD, Access & Reimbursement NPS RLT Remote- Houston, TX | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Dec 03, 2024 |
| Value Access Manager | Bogota (Oncology) / Cali (Pharmaceuticals) | Colombia | International | Innovative Medicines | Market Access | Dec 03, 2024 |
| Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Dec 03, 2024 |
| Innovative Access Partnerships and Engagement Manager | İstanbul Kavacık | Türkiye | International | Innovative Medicines | Market Access | Dec 03, 2024 |
| AD, Access & Reimbursement RLT Portland, OR - Remote | Field Non-Sales (USA) | USA | US | Innovative Medicines | Market Access | Dec 03, 2024 |
| Senior Public Affairs Manager (m/f/d) | Berlin West (Non-Sales Force) (Novartis Pharma GmbH) | Germany | International | Innovative Medicines | Market Access | Dec 03, 2024 |
| Manager Mature Brands, Established Medicines | Hyderabad (Office) | India | Finance | Innovative Medicines | Market Access | Dec 03, 2024 |
| Sr. HEOR & Access Strategy Manager | Beijing (Beijing) | China | International | Innovative Medicines | Market Access | Nov 29, 2024 |
| Solution & Service Design Manager | London (The Westworks) | United Kingdom | International | Innovative Medicines | Market Access | Aug 15, 2024 |
| Real World Evidence Research Analyst | Dublin (NOCC) | Ireland | Operations | CTS | Market Access | Aug 12, 2024 |
| New Products & Strategic Pricing Partner | Kyiv | Ukraine | International | Innovative Medicines | Market Access | Apr 16, 2024 |
| Patient Access Lead | Kyiv | Ukraine | International | Innovative Medicines | Market Access | Apr 16, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى